Neogenomics (NEO) Share-based Compensation Growth (3y) (2013 - 2026)
Neogenomics (NEO) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -20.63% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.52% |
| Dec 31, 2025 | 19.92% |
| Sep 30, 2025 | 34.03% |
| Jun 30, 2025 | 49.90% |
| Mar 31, 2025 | -3.86% |
| Dec 31, 2024 | -6.11% |
| Jun 30, 2024 | -64.59% |
| Mar 31, 2024 | 43.10% |
| Dec 31, 2023 | 37.72% |
| Mar 31, 2023 | 29.60% |
| Dec 31, 2022 | 27.06% |
| Sep 30, 2022 | 9.33% |
| Jun 30, 2022 | 16.17% |
| Mar 31, 2022 | 78.19% |
| Dec 31, 2021 | 77.25% |
| Sep 30, 2021 | 63.83% |
| Jun 30, 2021 | 24.54% |
| Mar 31, 2021 | 17.77% |
| Dec 31, 2020 | 62.04% |
| Sep 30, 2020 | 301.63% |